AbbVie: Fibromyalgia trials

The registry lists 10 Fibromyalgia studies with AbbVie as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 2 3Phase 3 5Phase 4 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary FibromyalgiaTerminatedNCT01331109Phase 2Results posted
• Safety and Efficacy of Milnacipran in Pediatric Patients With Primary FibromyalgiaTerminatedNCT01328002Phase 2Results posted
• Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of FibromyalgiaCompletedNCT01077375Phase 4Results posted
• Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of FibromyalgiaCompletedNCT01014585Phase 4Results posted
• Study of Milnacipran Added to Pregabalin for Treatment of FibromyalgiaCompletedNCT00797797Phase 3Results posted
• Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging (fMRI) Activation Patterns in Patients With FibromyalgiaTerminatedNCT00793520Phase 3Results posted
• A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure MonitoringCompletedNCT00618956Phase 3Results posted
• Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia SyndromeTerminatedNCT00445705Phase 2Results posted
• Study of Milnacipran for the Treatment of FibromyalgiaCompletedNCT00314249Phase 3Results posted
• Study of Milnacipran for the Treatment of FibromyalgiaCompletedNCT00098124Phase 3